Despite this, mouse models of tauopathy typically rely on pathogenic mutations to promote tau accumulation, and are commonly described as models of AD given their ability to recapitulate Alzheimer’s-like, neurofibrillary tau pathology (reviewed [3]). Here, MAPT is linked to Alzheimer disease.